首页> 外国专利> CD8+ REGULATORY T-CELLS FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS OF THE HUMAN GASTROINTESTINAL TRACT

CD8+ REGULATORY T-CELLS FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS OF THE HUMAN GASTROINTESTINAL TRACT

机译:CD8 +调节性T细胞,用于治疗人类胃肠道炎的炎症性疾病

摘要

The present invention relates to composition comprising an isolated CD8+ Treg cell population, wherein the Treg cells have signatures for i) identifying that the T-cells are CD8+ regulatory Tcells, ii) identifying that the Treg cells are tissue type tropic, i.e they can migrate to the diseased tissue, iii) optionally identifying that the Treg cells are tropic with respect to the diseased tissue, i.e. they are homing cells, iv) identifying that the Treg cells are emigrant cells, i.e. they originate from the target tissue, and v) optionally identifying that the Treg cells are capable of being retained in the target tissue and optionally one or more X-signatures and/or one or more Y-signatures.
机译:本发明涉及包含分离的CD8 + Treg细胞群的组合物,其中Treg细胞具有以下特征:i)识别T细胞是CD8 + 调节性T细胞, ii)识别Treg细胞是组织类型的,即它们可以迁移到患病组织,iii)可选地,识别Treg细胞相对于患病组织是嗜性的,即它们是归巢细胞,iv)识别Treg细胞细胞是移出的细胞,即它们源自靶组织,并且v)任选地鉴定Treg细胞能够被保留在靶组织中和任选地一种或多种X标记和/或一种或多种Y标记。

著录项

  • 公开/公告号US2017165298A1

    专利类型

  • 公开/公告日2017-06-15

    原文格式PDF

  • 申请/专利权人 GENOVIE AB;

    申请/专利号US201515303867

  • 发明设计人 REAGAN MICHEAL JARVIS;MAGNUS THÖRN;

    申请日2015-04-16

  • 分类号A61K35/17;G01N33/569;C12N5/0783;A61K9/08;A61K47/02;

  • 国家 US

  • 入库时间 2022-08-21 13:52:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号